|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"dai cy"
Showing items 1-25 of 101 (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2024-04-16 |
The efficacy of multi-disciplinary lifestyle modifications in Taiwanese nonalcoholic steatohepatitis patients
|
Yeh, ML;Dai, CY;Huang, CF;Huang, SF;Tsai, PC;Hsu, PY;Huang, C;Wei, YJ;Liang, PC;Bair, MJ;Lee, MH;Lin, ZY;Huang, JF;Yu, ML;Chuang, WL |
| 國家衛生研究院 |
2024-03 |
Air pollution as a potential a risk factor for hepatocellular carcinoma in Taiwanese patients after adjusting for chronic viral hepatitis
|
Jang, TY;Ho, CC;Wu, CD;Dai, CY;Chen, PC |
| 國家衛生研究院 |
2024-01-13 |
Comparative evaluation of pediatric fatty liver disease criteria: MASLD, ESPGHAN, NASPGHAN, and NAFLD - identifying the optimal pediatric label
|
Wang, CW;Huang, PC;Dai, CY;Huang, JF;Yu, ML |
| 國家衛生研究院 |
2023-11-10 |
Air pollution associate with advanced hepatic fibrosis among patients with chronic liver disease
|
Jang, TY;Ho, CC;Liang, PC;Wu, CD;Wei, YJ;Tsai, PC;Hsu, PY;Hsieh, MY;Lin, YH;Hsieh, MH;Wang, CW;Yang, JF;Yeh, ML;Huang, CF;Chuang, WL;Huang, JF;Cheng, YY;Dai, CY;Chen, PC;Yu, ML |
| 國家衛生研究院 |
2023-10-27 |
Pretreatment gamma-glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs
|
Jang, TY;Liang, PC;Jun, DW;Jung, JH;Toyoda, H;Wang, CW;Yuen, MF;Cheung, KS;Yasuda, S;Kim, SE;Yoon, EL;An, J;Enomoto, M;Kozuka, R;Chuma, M;Nozaki, A;Ishikawa, T;Watanabe, T;Atsukawa, M;Arai, T;Hayama, K;Ishigami, M;Cho, YK;Ogawa, E;Kim, HS;Shim, JJ;Uojima, H;Jeong, SW;Ahn, SB;Takaguchi, K;Senoh, T;Buti, M;Vargas-Accarino, E;Abe, H;Takahashi, H;Inoue, K;Huang, JF;Chuang, WL;Yeh, ML;Dai, CY;Huang, CF;Nguyen, MH;Yu, ML |
| 國家衛生研究院 |
2023-10-27 |
Air pollution impede ALT normalization in chronic hepatitis B patients treated with nucleotide/nucleoside analogues
|
Jang, TY;Ho, CC;Wu, CD;Dai, CY;Chen, PC |
| 國家衛生研究院 |
2021-08-12 |
First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients
|
Huang, JF;Dai, CY;Huang, CF;Tsai, PC;Yeh, ML;Hsu, PY;Huang, SF;Bair, MJ;Hou, NJ;Huang, CI;Liang, PC;Lin, YH;Wang, CW;Hsieh, MY;Chen, SC;Lin, ZY;Yu, ML;Chuang, WL |
| 中山醫學大學 |
2021 |
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng, PN; Mo, LR; Chen, CT; Chen, CY; Huang, CF; Kuo, HT; Lo, CC; Tseng, KC; Huang, YH; Tai, CM; Peng, CY; Bair, MJ; Chen, CH; Yeh, ML; Lin, CL; Lin, CY; Lee, PL; Chong, LW; Hung, CH; Chang, T; Huang, JF; Yang, CC; Hu, JT; Lin, CW; Wang, CC; Su, WW; Hsieh, TY; Lin, CL; Tsai, WL; Lee, TH; Chen, GY; Wang, SJ; Chang, CC; Yang, SS; Wu, WC; Huang, CS; Chou, KH; Kao, CN; Tsai, PC; Liu, CH; Lee, MH; Cheng, CY; Tsai, MC; Liu, CJ; Dai, CY; Lin, HC; Kao, JH; Chuang, WL; Yu, ML |
| 國家衛生研究院 |
2020-05 |
Risk of hepatitis C virus infection in injecting and non-injecting drug users receiving opioid substitution therapy
|
Wang, CW;Chuang, HY;Chiang, HC;Huang, PC;Yu, ML;Dai, CY |
| 國家衛生研究院 |
2020-05 |
Risk of hepatitis C virus infection in injecting and noninjecting drug users receiving opioid substitution therapy
|
Wang, CW;Chuang, HY;Chiang, HC;Huang, PC;Yu, ML;Dai, CY |
| 中山醫學大學 |
2020 |
IMPACT OF SOFOSBUVIR-BASED VERSUS NON-SOFOSBUVIR-BASED DIRECT-ACTING ANTIVIRALS ON RENAL FUNCTION IN CHRONIC HEPATITIS C PATIENTS WITH IMPAIRED RENAL FUNCTION- A LARGE COHORT STUDY FROM THE NATIONWIDE REAL-WORLD HCV REGISTRY PROGRAM (TACR)
|
Yu, ML; Chen, CY; Yi, C; Cheng, PN; Tseng, KC; Lo, CC; Hung, CH; Lin, CY; Chen, CH; Peng, CY; Bair, MJ; Hsieh, TY; Lee, PL; Yang, CC; Lin, CL; Mo, LR; Su, WW; Tsai, WL; Chang, CC; Lin, CC; Hsu, SJ; Liu, CH; Huang, YH; Hu, CT; Liu, CJ; Kao, JH; Lee, MH; Chien, RN; Dai, CY; Tsai, PC |
| 國家衛生研究院 |
2019-10 |
Urinary thiodiglycolic acid is associated with increased risk of non-alcoholic fatty liver disease in children living near a petrochemical complex
|
Wang, CW;Chuang, HY;Liao, KW;Yu, ML;Dai, CY;Chang, WT;Tsai, CH;Chiang, HC;Huang, PC |
| 國家衛生研究院 |
2017-01-04 |
The paradoxical effects of different Hepatitis C viral loads on host DNA damage and repair abilities
|
Wang, SC;Lai, KR;Li, CY;Chiang, CS;Yu, GY;Sakamoto, N;Tu, WY;Hsieh, MH;Huang, JF;Chuang, WL;Dai, CY;Yu, ML |
| 高雄醫學大學 |
2015 |
Chronic hepatitis C infection is associated with insulin resistance and lipid profiles
|
戴嘉言;葉明倫;黃釧峰;侯正修;謝明彥;黃志富;林怡伶;林子堯;陳信成;王良彥;張文宇;董宏達; Dai, CY;Yeh, ML;Huang, CF;Hou, CH;Hsieh, MY;Huang, JF;Lin, IL;Lin, ZY;Chen, SC;Wang, LY;Chuang, WL;Yu, ML;Tung HD, . |
| 高雄醫學大學 |
2014 |
Novel quasi-subgenotype D2 of hepatitis B virus identified in Taiwanese aborigines
|
Tran, H;余明隆;戴嘉言;林怡伶;葉明倫;莊萬龍;Abe, K; Tran, H;Yu, ML;Dai, CY;Lin, IL;Yeh, ML;Chuang, WL;Abe, K |
| 高雄醫學大學 |
2014 |
High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients
|
余明隆;戴嘉言;黃釧峰;李佳蓉;葉明倫;葉時孟;郭行道;黃志富;張哲銘;陳鴻鈞;卓夙航;黃尚志;莊萬龍; Yu, ML;Dai, CY;Huang, CF;Lee, JJ;Yeh, ML;Yeh, SM;Kuo, HT;Huang, JF;Chang, JM;Chen, HC;Juo, SH;Hwang, SJ;Chuang, WL;FORMOSA-LIKE, group. |
| 高雄醫學大學 |
2014 |
Impact of chronic hepatitis B and hepatitis C on adverse hepatic fibrosis in hepatocellular carcinoma related to betel quid chewing.
|
鄭貞英;蔡孟峰;蔡蕙如;莊麗月;林子堯;謝明裕;陳信成;莊萬龍;王良彥;余明隆;戴嘉言;蔡榮發; Jeng, JE;Tsai, MF;Tsai, HR;Chuang, LY;Lin, ZY;Hsieh, MY;Chen, SC;Chuang, WL;Wang, LY;Yu, ML;Dai, CY;Tsai, JF |
| 高雄醫學大學 |
2014 |
Abbott RealTime HBV Assay Is More Sensitive in Detection of Low Viral Load and Little Impacted by Drug Resistant Mutation in Chronic Hepatitis B Patients under Nucleot(s)ide Analogues Therapy.
|
葉明倫;黃釧峰;黃駿逸;劉淑芬;楊華齡;謝明彥;黃志富;戴嘉言;莊萬龍;余明隆; Yeh, ML;Huang, CF;Huang, CI;Liu, SF;Yang, HL;Hsieh, MY;Huang, JF;Dai, CY;Chuang, WL;Yu, ML |
| 高雄醫學大學 |
2014 |
inosine triphosphate pyrophosphatase 基因變異與慢性C型肝炎2/3基因型治療復發危險
|
戴嘉言;莊萬龍;余明隆; Dai, CY;Chuang, WL;Yu, ML |
| 高雄醫學大學 |
2014 |
A 24-Week Pegylated Interferon Alpha-2b Versus a 12-Week Pegylated Interferon Alpha-2b Alone or With Ribavirin for Patients With Acute Hepatitis C
|
戴嘉言;莊萬龍;余明隆; Dai, CY;Chuang, WL;ML*, Yu |
| 高雄醫學大學 |
2014 |
Urinary transforming growth factor α and serum α-fetoprotein as tumor markers of hepatocellular carcinoma
|
鄭貞英;蔡孟峰(共同第一);蔡蕙如(共同第一);莊麗月;林子堯;謝明裕;陳信成;莊萬龍;王良彥;余明隆;戴嘉言;蔡榮發; Jeng, JE;Tsai, MF;Tsia, HR;Chuang, LY;Lin, ZY;Hsieh, MY;Chen, SC;Chuang, WL;Wang, LY;Yu, ML;Dai, CY;Tsai, JF |
| 高雄醫學大學 |
2014 |
Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study
|
鄭貞英;吳慧芳;蔡孟峰;蔡蕙如;莊麗月;林子堯;謝明裕;陳信成;莊萬龍;王良彥;余明隆;戴嘉言;蔡榮發; Jeng, JE;Wu, HF;Tsai, MF;Tsai, HR;Chuang, LY;Lin, ZY;Hsieh, MY;Chen, SC;Chuang, WL;Wang, LY;Yu, ML;Dai, CY;Tsai, JF |
| 中國醫藥大學 |
2013-03 |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced HBeAg seroconversion
|
(Yang HC);(Chen CL);(Shen YC);彭成元(Cheng-Yuan Peng);(Liu CJ);(Tseng TC);(Su TH);(Chuang WL);(Yu ML);(Dai CY);(Liu CH);(Chen PJ);(Chen DS);(Kao JH)* |
| 國家衛生研究院 |
2013-01 |
Randomised clinical trial: Comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma
|
Shiah, HS;Chen, CY;Dai, CY;Hsiao, CF;Lin, YJ;Su, WC;Chang, JY;Whang-Peng, J;Lin, PW;Huang, JD;Chen, LT |
| 高雄醫學大學 |
2013 |
Pegylated interferon and ribavirin: A therapeutic option in patients who fail to respond to telaprevir-based triple therapy?
|
戴嘉言;莊萬龍;余明隆 ; Dai, CY;Chuang, WL;Yu, ML. |
Showing items 1-25 of 101 (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page
|
